Author Archive: Abigail Hirsch

Abigail Hirsch

Abigail is the Director of Events Communications at BIO. Although she has lived in the Washington, DC, area for nearly eight years, she still considers Virginia Beach home, especially with her parents and closest friends still in the area. According to Abigail, there is nothing better than sitting on the beach with a good book and cold drink. In her spare time, she enjoys visiting antique stores, finishing her twin sister Brooke’s sentences and spending time with her two boys, Frank her English bulldog, and JP her soon-to-be husband. Check back often for updates, Abigail’s take on BIO related events, and much more. And please, be kind, this is her first venture in to the blogging world!

Latest Posts

Tekmira Pharmaceuticals Ebola Drug Gets Nod From FDA

BIF_logo

The U.S. Food and Drug Administration has authorized Canada’s Tekmira Pharmaceuticals to provide an experimental drug to people with confirmed or suspected Ebola virus infections, according to an article in The Wall Street Journal. “Our TKM-Ebola drug supplies are limited, but we will continue to help where we can,” Tekmira Chief Executive Mark J. Murray said in a press release. The drug is still in clinical testing to assess whether it is safe and effective. BIO Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

The Eyes Have It According to Recent VC Funding Patterns

BIF_logo

A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which human body parts are experiencing the biggest rise in funding. The report was based on data from thousands of financings of startups from 1999 through the first half of 2014, provided by VentureSource, a database owned by Dow Jones & Company. And while many would assume the funding was largely pumped in to cardiovascular disease, they would be wrong. “The Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO 2015 Program Co-Chair Asks the Question – Will You Be A Change Agent?

bio_convention_logo

In a recent blog post, Rob Wright of Life Science Leader challenges biotechnology, pharmaceutical, business development, life sciences and policy experts to be a change agent in 2015 and submit a topic proposal for sessions at the 2015 BIO International Convention. “Don’t let BIO’s size keep you on the sidelines as a bystander. Don’t assume someone else will step up or has better wisdom to share. Instead, I challenge you to submit a session proposal Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Buzz of BIO winners at the 2014 BIO Investor Forum™

BIF-BuzzofBIO-116x76

Buzz of BIO winners amongst the most innovative companies at the 2014 BIO Investor Forum™ Building on the success of the Buzz of BIO competition at the BIO International Convention, BIO recently hosted a similar competition for the upcoming BIO Investor Forum. The first Buzz of BIO at the BIO Investor Forum competition featured 18 nominees pulling in over 1,300 votes. The winners are: Winner: Early Stage Entrepreneurs BNOAT Oncology, Inc. (Akron, Ohio) BNOAT Oncology Read More >

Events  |  Leave a comment  |  Email This Post

BIO Latin America Program Highlights

LatinAmerica_205x100_Thumbnail copy

BIO Latin America is just one short month away, September 9-11 in Rio de Janeiro, Brazil, and with this in mind BIO has announced the preliminary program as well as an initial list of presenting companies. Program topics include: Regional Biotech Development: Frameworks for Innovation Incentivizing Entrepreneurship and Investment in Latin America The Innovation Ecosystem in Brazil: From Biofuels to Biotherapeutics Tech Transfer: Industry and University Collaborations Regional Regulations for Biotherapeutics Clinical Trials: Addressing Challenges Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,